TipRanks
Nabriva Therapeutics (NBRVF)
OTHER OTC:NBRVF
US Market
NBRVF
Nabriva Therapeutics
RESEARCH TOOLSreports

Nabriva Therapeutics (NBRVF) Balance Sheet

1,011 Followers

Nabriva Therapeutics Balance Sheet

Nabriva Therapeutics's total assets for Q2 2023 were $10.58M, a decrease of -56.54% from the previous quarter. NBRVF total liabilities were $26.90M for the fiscal quarter, a -6.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 31.77M$ 80.91M$ 58.44M$ 94.11M$ 110.42M
Total Liabilities
$ 28.47M$ 27.56M$ 25.30M$ 52.84M$ 41.79M
Total Equity Gross Minority
$ 3.29M$ 53.35M$ 33.13M$ 41.27M$ 68.63M
Other Metrics
Currency in USD

Nabriva Therapeutics Debt to Assets